Skip to content

Brainsway Deep Transcranial Magnetic Stimulation (DTMS) System

by Brainways, Ltd.

De Novo DEN170078

Active United States

De Novo

Valid until

No expiry

De Novo grant is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA De Novo, synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA De NovoDENG De Novo granted · Direct NumberDEN170078 Date17 Aug 2018DecidedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA De Novo Active

Specification

De Novo

De Novo Number
FDA Product Code
QCI
FDA applicant
Brainways , Ltd.
Device Class
Class II
Regulation
21 CFR Part 882.5802
Advisory Committee
Neurology
FDA Decision
DENG De Novo granted